Table 1 Basic characteristics of study participants.
Variables (Mean ± SE or Weighted%) | Overall (n = 1776) | NO-sarcopenia group (n = 1184) | Sarcopenia group (n = 592) | P |
|---|---|---|---|---|
Age (Year) | 45.57 (10.75) | 45.30 (10.40) | 46.11 (11.40) | 0.006 |
Sex (Male) | 1208 (68.0) | 816 (68.9) | 392 (66.2) | 0.273 |
Race (%) | 0.034 | |||
White | 832 (46.8) | 568 (48.0) | 264 (44.6) | |
Black | 288 (16.2) | 192 (16.2) | 96 (16.2) | |
Mexican | 360 (20.3) | 248 (20.9) | 112 (18.9) | |
Other | 296 (16.7) | 176 (14.9) | 120 (20.3) | |
Marital status (%) | 0.702 | |||
Married | 792 (44.6) | 520 (43.9) | 272 (45.9) | |
Never married | 448 (25.2) | 304 (25.7) | 144 (24.3) | |
Widowed, divorced, or separated | 536 (30.2) | 360 (30.4) | 176 (29.7) | |
Education (%) | 0.022 | |||
High School | 480 (27.0) | 328 (27.7) | 152 (25.7) | |
Less than 9th grade | 64 (3.6) | 32 (2.7) | 32 (5.4) | |
9-11th Grade | 336 (18.9) | 232 (19.6) | 104 (17.6) | |
College graduate or above | 896 (50.5) | 592 (50.0) | 304 (51.4) | |
PIR (%) | 0.312 | |||
0.00–1.00 | 520 (29.3) | 344 (29.1) | 176 (29.7) | |
1.00–3.00 | 880 (49.5) | 600 (50.7) | 280 (47.3) | |
>3.00 | 376 (21.2) | 240 (20.3) | 136 (23.0) | |
Hypertension = 1 (%) | 1240 (69.8) | 816 (68.9) | 424 (71.6) | 0.265 |
Stroke (Yes, %) | 56 (3.2) | 32 (2.7) | 24 (4.1) | 0.164 |
CKD (Yes, %) | 496 (27.9) | 336 (28.4) | 160 (27.0) | 0.588 |
COPD (Yes, %) | 128 (7.2) | 96 (8.1) | 32 (5.4) | 0.048 |
DM (Yes, %) | 664 (37.4) | 448 (37.8) | 216 (36.5) | 0.615 |
Smoke (%) | 0.009 | |||
Former | 352 (19.8) | 216 (18.2) | 136 (23.0) | |
Never | 1000 (56.3) | 664 (56.1) | 336 (56.8) | |
Now | 424 (23.9) | 304 (25.7) | 120 (20.3) | |
BMI (kg/m2) | 35.15 (9.62) | 30.74 (6.28) | 43.97 (9.06) | < 0.001 |
Alcohol consumption (Yes, %) | 328 (18.5) | 216 (18.2) | 112 (18.9) | 0.779 |
WBC (×1012/L) | 8.13 (2.65) | 7.88 (2.69) | 8.65 (2.50) | < 0.001 |
Neu (×1012/L) | 60.35 (9.43) | 59.66 (10.02) | 61.74 (7.95) | < 0.001 |
Lym (×1012/L) | 2.28 (0.81) | 2.26 (0.86) | 2.31 (0.70) | 0.004 |
Hb (g/L) | 14.50 (1.63) | 14.57 (1.72) | 14.35 (1.41) | 0.007 |
PLT (×1012/L) | 245.59 (67.50) | 243.53 (66.27) | 249.70 (69.77) | 0.794 |
CK (U/L) | 165.55 (191.79) | 164.50 (155.45) | 167.64 (249.18) | 0.179 |
LDH (U/L) | 130.25 (29.15) | 124.73 (23.66) | 141.30 (35.31) | < 0.001 |
SII | 580.44 (327.45) | 555.72 (322.70) | 629.86 (331.53) | < 0.001 |
Survive (Yes, %) | 136 (7.7) | 80 (6.8) | 56 (9.5) | 0.054 |
Death reason (%) | 0.022 | |||
Cancer | 8 (0.5) | 8 (0.7) | 0 (0.0) | |
DM | 24 (1.4) | 16 (1.4) | 8 (1.4) | |
Heart disease | 40 (2.3) | 24 (2.0) | 16 (2.7) | |
Lung disease | 16 (0.9) | 8 (0.7) | 8 (1.4) | |
No | 1640 (92.3) | 1104 (93.2) | 536 (90.5) | |
Others | 48 (2.7) | 24 (2.0) | 24 (4.1) | |
Follow-up (Day) | 82.44 (18.54) | 83.86 (16.22) | 79.61 (22.22) | 0.011 |
